These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17252258)

  • 1. [Bisphosphonates in osteoporosis therapy. Standards and perspectives].
    Reinsdorf S; Habermann B; Hochmuth K; Kurth AA
    Orthopade; 2007 Feb; 36(2):110-7. PubMed ID: 17252258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bisphosphonate therapy for children and adolescents with primary and secondary osteoporotic diseases].
    Semler O; Land C; Schönau E
    Orthopade; 2007 Feb; 36(2):146-51. PubMed ID: 17252257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2009 Jan; 19(1):44-53. PubMed ID: 19122264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bisphosphonate].
    Hagino H
    Nihon Rinsho; 2015 Oct; 73(10):1683-9. PubMed ID: 26529930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates.
    McClung M
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):735-44. PubMed ID: 17117298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of bisphosphonates for osteoporosis or osteopenia in Crohn's disease: a meta-analysis.
    Guo Z; Wu R; Gong J; Zhu W; Li Y; Li N; Li J
    Dig Dis Sci; 2013 Apr; 58(4):915-22. PubMed ID: 23179146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Zoledronic acid reduces risk of any new clinical fracture and risk of death after surgical repair of a low-trauma hip fracture].
    Leszczyński P
    Chir Narzadow Ruchu Ortop Pol; 2010; 75(3):168-71. PubMed ID: 21038635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minodronate for the treatment of osteoporosis.
    Kubo T; Shimose S; Matsuo T; Fujimori J; Ochi M
    Drugs Today (Barc); 2010 Jan; 46(1):33-7. PubMed ID: 20200694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibandronate: A Review in Japanese Patients with Osteoporosis.
    Keating GM
    Drugs Aging; 2016 Apr; 33(4):295-303. PubMed ID: 26915075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of pharmaceutical intervention in the treatment of osteoporosis and prevention of fracture].
    Nakamura T
    Nihon Rinsho; 2009 May; 67(5):903-8. PubMed ID: 19432107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The successful development of bisphosphonates in the therapy of osteoporosis].
    Fassbender WJ; Stumpf UC; Kurth A
    Med Klin (Munich); 2006 Jun; 101 Suppl 1():6-14. PubMed ID: 16826363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bisphosphonate].
    Hagino H
    Nihon Rinsho; 2011 Jul; 69(7):1253-7. PubMed ID: 21774367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of bisphosphonates on fracture healing].
    Seebach C; Kurth A; Marzi I
    Orthopade; 2007 Feb; 36(2):136-40. PubMed ID: 17242960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fracture risk and zoledronic acid therapy in men with osteoporosis.
    Boonen S; Reginster JY; Kaufman JM; Lippuner K; Zanchetta J; Langdahl B; Rizzoli R; Lipschitz S; Dimai HP; Witvrouw R; Eriksen E; Brixen K; Russo L; Claessens F; Papanastasiou P; Antunez O; Su G; Bucci-Rechtweg C; Hruska J; Incera E; Vanderschueren D; Orwoll E
    N Engl J Med; 2012 Nov; 367(18):1714-23. PubMed ID: 23113482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous ibandronate or sodium-fluoride--a 3.5 years study on bone density and fractures in Crohn's disease patients with osteoporosis.
    Klaus J; Reinshagen M; Herdt K; Adler G; von Boyen GB; von Tirpitz C
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):141-8. PubMed ID: 21725510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates in the treatment of metabolic bone diseases.
    Arantes HP; Silva AG; Lazaretti-Castro M
    Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):206-12. PubMed ID: 20485910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates for the prevention and treatment of osteoporosis.
    Maraka S; Kennel KA
    BMJ; 2015 Sep; 351():h3783. PubMed ID: 26333528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonates for osteoporosis--where do we go from here?
    Whitaker M; Guo J; Kehoe T; Benson G
    N Engl J Med; 2012 May; 366(22):2048-51. PubMed ID: 22571168
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inflammation of the jaws during treatment with bisphosphonates].
    Bartl R
    Dtsch Med Wochenschr; 2011 Oct; 136(41):2109-10. PubMed ID: 21971888
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differences among bisfosfonates--specificity of risedronate (Actonel)].
    Giljević Z
    Reumatizam; 2008; 55(2):78-80. PubMed ID: 19024283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.